✦ LIBER ✦

PHM12 COST-EFFECTIVENESS OF DASATINIBVS IMATINIB 800 MG/ DAY IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN

✍ Scribed by M Brosa; MJ Taylor; U Staginnus; A Meno Duran; KH Cerri; F Cervantes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN69 COST-EFFECTIVENESS ANALYSIS OF DAS

✍ de Ramirez; A Arellano; U Sbarigia; MJ Taylor; P Martin; G Restovic 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCN13 Cost-Effectiveness Analysis of Nil

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN99 Cost-Effectiveness of Dasatinib ve

✍ Darba, J.; Kaskens, L.; Abecasis, M.; Vitorino, R.; Carrasco, J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN14 THE COST AND COST EFFECTIVENESS OF

✍ Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Lital 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN34 BUDGET IMPACT ANALYSIS OF DASATINI

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PSY17 THE COST AND COST EFFECTIVENESS OF

✍ A Juarez-Garcia; L Zapata; G Vega; J Idrovo; R Rivas; JL Kramis; G Litalien; S R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB